Literature DB >> 30531978

Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis.

Su-Jin Park1,2, Young-Il Kim1,2, Angela Park3, Hyeok-Il Kwon1,2, Eun-Ha Kim1,2, Young-Jae Si1,2, Min-Suk Song1,2, Chul-Ho Lee4, Kyle Jung3, Woo-Jin Shin3, Jianxiong Zeng3, Younho Choi3, Jae U Jung5, Young Ki Choi6,7.   

Abstract

Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV), listed in the most dangerous pathogens by the World Health Organization, has 12-30% fatality rates with a characteristic thrombocytopenia syndrome. With a majority of clinically diagnosed SFTSV patients older than ~50 years of age, age is a critical risk factor for SFTSV morbidity and mortality. Here, we report an age-dependent ferret model of SFTSV infection and pathogenesis that fully recapitulates the clinical manifestations of human infections. Whereas young adult ferrets (≤2 years of age) did not show any clinical symptoms and mortality, SFTSV-infected aged ferrets (≥4 years of age) demonstrated severe thrombocytopenia, reduced white blood cell counts and high fever with 93% mortality rate. Moreover, a significantly higher viral load was observed in aged ferrets. Transcriptome analysis of SFTSV-infected young ferrets revealed strong interferon-mediated anti-viral signalling, whereas inflammatory immune responses were markedly upregulated and persisted in aged ferrets. Thus, this immunocompetent age-dependent ferret model should be useful for anti-SFTSV therapy and vaccine development.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30531978      PMCID: PMC6548318          DOI: 10.1038/s41564-018-0317-1

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  27 in total

1.  Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South Korea.

Authors:  Seok-Min Yun; Su-Jin Park; Young-Il Kim; Sun-Whan Park; Min-Ah Yu; Hyeok-Il Kwon; Eun-Ha Kim; Kwang-Min Yu; Hye Won Jeong; Jungsang Ryou; Won-Ja Lee; Youngmee Jee; Joo-Yeon Lee; Young Ki Choi
Journal:  JCI Insight       Date:  2020-01-30

2.  Derivation of induced pluripotent stem cells from ferret somatic cells.

Authors:  Jinghui Gao; Sophia Petraki; Xingshen Sun; Leonard A Brooks; Thomas J Lynch; Chih-Lin Hsieh; Reem Elteriefi; Zareeb Lorenzana; Vasu Punj; John F Engelhardt; Kalpaj R Parekh; Amy L Ryan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-19       Impact factor: 5.464

3.  Severe Fever with Thrombocytopenia Syndrome Virus NSs Interacts with TRIM21 To Activate the p62-Keap1-Nrf2 Pathway.

Authors:  Younho Choi; Zhongyi Jiang; Woo-Jin Shin; Jae U Jung
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

4.  A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo.

Authors:  Xilin Wu; Yanlei Li; Bilian Huang; Xiaohua Ma; Linjing Zhu; Nan Zheng; Shijie Xu; Waqas Nawaz; Changping Xu; Zhiwei Wu
Journal:  JCI Insight       Date:  2020-07-09

5.  Effect of genomic variations in severe fever with thrombocytopenia syndrome virus on the disease lethality.

Authors:  Zi-Niu Dai; Xue-Fang Peng; Jia-Chen Li; Jing Zhao; Yong-Xiang Wu; Xin Yang; Tong Yang; Shao-Fei Zhang; Ke Dai; Xiu-Gang Guan; Chun Yuan; Zhen-Dong Yang; Ning Cui; Qing-Bin Lu; Yong Huang; Hang Fan; Xiao-Ai Zhang; Geng-Fu Xiao; Ke Peng; Lei-Ke Zhang; Wei Liu; Hao Li
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

6.  Infection Route Impacts the Pathogenesis of Severe Fever with Thrombocytopenia Syndrome Virus in Ferrets.

Authors:  Su-Jin Park; Young-Il Kim; Mark Anthony Casel; Eun-Ha Kim; Se-Mi Kim; Kwang-Min Yu; Rare Rollon; Seung-Gyu Jang; Hye Won Jeong; Young Ki Choi
Journal:  Viruses       Date:  2022-05-29       Impact factor: 5.818

7.  Severe fever with thrombocytopenia syndrome virus targets B cells in lethal human infections.

Authors:  Tadaki Suzuki; Yuko Sato; Kaori Sano; Takeshi Arashiro; Harutaka Katano; Noriko Nakajima; Masayuki Shimojima; Michiyo Kataoka; Kenta Takahashi; Yuji Wada; Shigeru Morikawa; Shuetsu Fukushi; Tomoki Yoshikawa; Masayuki Saijo; Hideki Hasegawa
Journal:  J Clin Invest       Date:  2020-02-03       Impact factor: 14.808

8.  Dissolving immune cell membranes.

Authors:  Ashley York
Journal:  Nat Rev Microbiol       Date:  2019-01       Impact factor: 60.633

Review 9.  Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy.

Authors:  Mark Anthony Casel; Su Jin Park; Young Ki Choi
Journal:  Exp Mol Med       Date:  2021-05-06       Impact factor: 8.718

Review 10.  COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives.

Authors:  Masataka Nishiga; Dao Wen Wang; Yaling Han; David B Lewis; Joseph C Wu
Journal:  Nat Rev Cardiol       Date:  2020-07-20       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.